Mostly, miRNAs such as miR-219-5p, miR-485-5P, and miR-194 inhibit HCC progression by targeting GPC3 and inhibition of Wnt/β-catenin signaling [139,140]. Here, GPC3 is linked to hepatocellular carcinoma.